Cargando…

Dose matters for stereotactic body radiotherapy for early stage non-small cell lung cancer

Detalles Bibliográficos
Autores principales:	Okoye, Christian C., Cho, C. Jane, Liu, Mitchell, Louie, Alexander V., Obayomi-Davies, Olusola, Siva, Shankar, Lo, Simon S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576082/ https://www.ncbi.nlm.nih.gov/pubmed/33241046 http://dx.doi.org/10.21037/atm-20-3149

Ejemplares similares

Complications from Stereotactic Body Radiotherapy for Lung Cancer
por: Kang, Kylie H., et al.
Publicado: (2015)

Stereotactic Body Radiotherapy for Oligometastatic Disease in Non-small Cell Lung Cancer
por: Wujanto, Caryn, et al.
Publicado: (2019)

Stereotactic Body Radiotherapy for Primary Prostate Cancer
por: Kothari, Gargi, et al.
Publicado: (2018)

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
por: Tran, Kevin T., et al.
Publicado: (2023)

Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors
por: Lischalk, Jonathan W., et al.
Publicado: (2018)

Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens
por: Siva, Shankar, et al.
Publicado: (2016)

The role of technology in clinical trials using stereotactic body radiotherapy
por: Aznar, Marianne, et al.
Publicado: (2017)

Safety of high-dose-rate stereotactic body radiotherapy
por: Stieb, Sonja, et al.
Publicado: (2015)

Stereotactic Body Radiotherapy for Early Stage Lung Cancer
por: Nagata, Yasushi
Publicado: (2013)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations
por: Ricco, Anthony, et al.
Publicado: (2020)

Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
por: Rühle, Alexander, et al.
Publicado: (2019)

Multi-center evaluation of dose conformity in stereotactic body radiotherapy
por: Lee, Jonny, et al.
Publicado: (2019)

Low-Dose Radiotherapy for Late-Stage COVID-19 Pneumonia?
por: Koukourakis, Michael I.
Publicado: (2020)

Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy
por: Grimm, Jimm, et al.
Publicado: (2011)

Analysis of Biologically Equivalent Dose of Stereotactic Body Radiotherapy for Primary and Metastatic Lung Tumors
por: Park, Sungkwang, et al.
Publicado: (2014)

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
por: Ma, Ting Martin, et al.
Publicado: (2020)

Potency preservation following stereotactic body radiation therapy for prostate cancer
por: Obayomi-Davies, Olusola, et al.
Publicado: (2013)

Developments in Stereotactic Body Radiotherapy
por: Haridass, Anoop
Publicado: (2018)

Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
por: David, Steven, et al.
Publicado: (2019)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer: more than a simple “MIRAGE”?
por: Bosetti, Davide Giovanni, et al.
Publicado: (2023)

Doses, fractionations, constraints for stereotactic radiotherapy
por: Borghesi, Simona, et al.
Publicado: (2022)

The dosimetric impact of implants on the spinal cord dose during stereotactic body radiotherapy
por: Yazici, Gozde, et al.
Publicado: (2016)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation
por: Chen, Hanbo, et al.
Publicado: (2018)

Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer
por: Al Feghali, Karine A., et al.
Publicado: (2020)

Establishing the Role of Stereotactic Ablative Body Radiotherapy in Early-Stage Breast Cancer
por: Barry, Aisling, et al.
Publicado: (2018)

Stereotactic Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Rationale, Feasibility, and Early Experience Using the CyberKnife Radiosurgery Delivery Platform
por: Obayomi-Davies, Olusola, et al.
Publicado: (2016)

Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis
por: Poon, Ian, et al.
Publicado: (2020)

The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma
por: Barbour, Andrew B., et al.
Publicado: (2023)

Dose escalation in the era of ablative lung irradiation: is more dose better when it comes to delivery of lung stereotactic body radiation therapy?
por: Alite, Fiori, et al.
Publicado: (2020)

Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
por: Alomran, Reem, et al.
Publicado: (2021)

An optimal dose‐fractionation for stereotactic body radiotherapy in peripherally, centrally and ultracentrally located early‐stage non‐small lung cancer
por: Zarębska, Izabela, et al.
Publicado: (2023)

Intratumoural renal cell carcinoma haemorrhage following stereotactic radiotherapy: a case report
por: Hilleary, Liam A., et al.
Publicado: (2019)

Commentary: Stereotactic body radiation therapy versus surgery for stage I non–small cell lung cancer in healthy patients: Not quite there yet
por: Sideris, Antonios, et al.
Publicado: (2022)

Is internal target volume accurate for dose evaluation in lung cancer stereotactic body radiotherapy?
por: Peng, Jiayuan, et al.
Publicado: (2016)

Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy
por: Wang, Shuo, et al.
Publicado: (2019)

Evaluation of Automated Treatment Planning and Organ Dose Prediction for Lung Stereotactic Body Radiotherapy
por: Ouyang, Zi, et al.
Publicado: (2021)

Harmonization of dose prescription for lung stereotactic radiotherapy
por: Beldjoudi, Guillaume, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1luijpepgh4copplvtpdbgk2ko